$0.6608
-0.0702-9.6%
Last update: Oct 30, 9:16 AM
Lantern Pharma Inc (LTRN) Stock Price, Quote, News & History
LTRNNASDAQ
Lantern Pharma shares rebound in premarket trading as the company debunks a false report regarding CEO Panna Sharma's departure.
You can purchase shares of Lantern Pharma (NASDAQ:LTRN) through any online brokerage.
Other companies in Lantern Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Lantern Pharma has a consensus price target of $25.00.
The stock price for Lantern Pharma (NASDAQ: LTRN) is $0.725 last updated October 30, 2026 at 9:16 AM EDT.
There are no upcoming dividends for Lantern Pharma.
Lantern Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Lantern Pharma.
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies...
